CLINICAL_TRIALS trial_result · 2017-04-26

Clinical Trial Update: Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer [Phase 3]

Phase 3 trial evaluating duloxetine for chemotherapy-induced peripheral neuropathy in cancer patients has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Neurotoxicity, Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-04-26